Full View

Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice

Y Chen, Y Duan, X Yang, L Sun, M Liu… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …
被引用次数：105 相关文章 Full View

Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice

Y Chen, Y Duan, X Yang, L Sun… - Arteriosclerosis …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …
[PDF] psu.edu

[PDF][PDF] Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice

Y Chen, Y Duan, X Yang, L Sun, M Liu, Q Wang… - … Thromb Vasc Biol, 2015 - Citeseer
Objective—Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …

Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice

Y Chen, Y Duan, X Yang, L Sun, M Liu… - … , and Vascular Biology, 2015 - cir.nii.ac.jp
< jats: sec>< jats: title> Objective—</jats: title>< jats: p> Activation of liver X receptor (LXR)
inhibits atherosclerosis but induces hypertriglyceridemia. In vitro, it has been shown that …
[PDF] researchgate.net

[PDF][PDF] Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice

Y Chen, Y Duan, X Yang, L Sun, M Liu, Q Wang, X Ma… - 2015 - researchgate.net
Objective—Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …

Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice

Y Chen, Y Duan, X Yang, L Sun, M Liu… - Arteriosclerosis …, 2015 - ingentaconnect.com
Objective—Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …

Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice

Y Chen, Y Duan, X Yang, L Sun, M Liu, Q Wang, X Ma… - 2015 - Am Heart Assoc
Objective—Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …

Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.

Y Chen, Y Duan, X Yang, L Sun, M Liu… - … and Vascular Biology, 2015 - europepmc.org
Objective Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …
[PDF] archive.org

[PDF][PDF] Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice

Y Chen, Y Duan, X Yang, L Sun, M Liu, Q Wang, X Ma… - 2015 - scholar.archive.org
Objective—Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …

Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice

Y Chen, Y Duan, X Yang, L Sun, M Liu… - … , and Vascular Biology, 2015 - hero.epa.gov
OBJECTIVE: Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …